ProQuad FDA Approval History
FDA Approved: Yes (First approved September 6, 2005)
Brand name: ProQuad
Generic name: measles, mumps, rubella and varicella virus vaccine, live
Dosage form: Injection
Company: Merck & Co., Inc.
Treatment for: Mumps Prophylaxis, Measles Prophylaxis, Rubella Prophylaxis, Varicella-Zoster, Prophylaxis
ProQuad (measles, mumps, rubella and varicella virus vaccine, live) is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age.
Development timeline for ProQuad
|Sep 6, 2005||Approval Proquad Merck & Co., Inc. - Treatment for Measles, Mumps, Rubella and Varicella Vaccination|
|Nov 4, 2004||Merck Files Biologics License Application for Proquad With U.S. Food and Drug Administration|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.